These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12771472)

  • 1. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma.
    Huh CH; Seo KI; Park JY; Lim JG; Eun HC; Park KC
    Dermatology; 2003; 206(4):316-20. PubMed ID: 12771472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma.
    Sobhi RM; Sobhi AM
    J Cosmet Dermatol; 2012 Mar; 11(1):65-71. PubMed ID: 22360337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo.
    Choi YK; Rho YK; Yoo KH; Lim YY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK; Kim DS
    Int J Dermatol; 2010 Feb; 49(2):218-26. PubMed ID: 20465650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ascorbic acid on gingival melanin pigmentation in vitro and in vivo.
    Shimada Y; Tai H; Tanaka A; Ikezawa-Suzuki I; Takagi K; Yoshida Y; Yoshie H
    J Periodontol; 2009 Feb; 80(2):317-23. PubMed ID: 19186973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Guo L; Liu X; Liu Q; Xie X; Jiang X
    Drug Des Devel Ther; 2024; 18():3659-3666. PubMed ID: 39185080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study.
    Balevi A; Ustuner P; Özdemir M
    J Cosmet Laser Ther; 2017 Oct; 19(5):294-299. PubMed ID: 28388246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of 25% L-ascorbic acid (C'ensil) in the treatment of melasma.
    Hwang SW; Oh DJ; Lee D; Kim JW; Park SW
    J Cutan Med Surg; 2009; 13(2):74-81. PubMed ID: 19298775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stepwise approach to the treatment of melasma.
    Perez MI
    Cutis; 2005 Apr; 75(4):217-22. PubMed ID: 15916218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double Blind, Placebo Controlled Evaluation of a Novel Skin Lightening Agent.
    Spencer JM; Accioly J; Kitchen N
    J Drugs Dermatol; 2018 Jan; 17(1):113-115. PubMed ID: 29320596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
    Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
    J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.
    Lee GS
    J Cosmet Laser Ther; 2008 Dec; 10(4):234-6. PubMed ID: 18830869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, dermoscopic, and histopathologic evaluation of vitamin C versus PRP, with microneedling in the treatment of mixed melasma: A split-face, comparative study.
    Abdel-Rahman AT; Abdel-Hakeem FG; Ragaie MH
    Dermatol Ther; 2022 Feb; 35(2):e15239. PubMed ID: 34851010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2009 Aug; 8(8):732-5. PubMed ID: 19663110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.